Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers

© International Society of Travel Medicine 2023. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissionsoup.com..

BACKGROUND: Artemisinin-based combination therapy (ACT) for the treatment of malaria is highly effective, well tolerated and safe. Episodes of delayed haemolysis occur in up to 57.9% of patients with severe malaria treated with intravenous artesunate, mainly caused by 'pitting' of infected red blood cells in the spleen and the delayed loss of these once-infected RBCs (oiRBCs). Several reports indicate that post-treatment haemolysis (PTH) also occurs in uncomplicated malaria treated with oral ACT, calling for systematic investigation.

METHODS: A prospective observational study to identify the incidence of PTH after oral ACT, defined as increased lactate dehydrogenase activity and low haptoglobin level on Day 14 after treatment. Patients were enrolled at two study centres in Germany and Italy. Study visits took place on Days 1, 3, 7, 14 and 28. Laboratory investigations included extended clinical routine laboratory tests, quantitative PfHRP2, anti-RBC antibodies and oiRBCs. The state of semi-immunity to malaria was assessed from childhood and ongoing exposure to Plasmodium spp. as per patient history.

RESULTS: A total of 134 patients with uncomplicated malaria and 3-day ACT treatment were recruited. Thirty-seven (37.4%) of 99 evaluable patients with Pf and none of 9 patients with non-Pf malaria exhibited PTH on d14. Patients with PTH had higher initial parasitaemia, higher oiRBC counts on d3 and a 10-fold decrease in oiRBCs between d7 and d14 compared with patients without PTH. In patients with PTH, loss of haemoglobin was 4-fold greater in non-Africans than in Africans (-1.3 vs -0.3 g/dl). Semi-immune African patients with PTH showed markedly increased erythropoiesis on d14 compared with not semi-immune African and non-African patients with PTH.

CONCLUSIONS: PTH is common in patients with uncomplicated malaria and oral ACT. While the observed loss of haemoglobin will often not be clinically relevant, it could aggravate pre-existing anaemia, warranting follow-up examinations in populations at risk.

Errataetall:

CommentIn: J Travel Med. 2023 May 18;30(3):. - PMID 36799808

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Journal of travel medicine - 30(2023), 3 vom: 18. Mai

Sprache:

Englisch

Beteiligte Personen:

Kurth, Florian [VerfasserIn]
Tober-Lau, Pinkus [VerfasserIn]
Lingscheid, Tilman [VerfasserIn]
Bardtke, Lara [VerfasserIn]
Kim, Johanna [VerfasserIn]
Angheben, Andrea [VerfasserIn]
Gobbi, Federico G [VerfasserIn]
Mbavu, Lena [VerfasserIn]
Stegemann, Miriam S [VerfasserIn]
Heim, Katrin M [VerfasserIn]
Pfäfflin, Frieder [VerfasserIn]
Menner, Nikolai [VerfasserIn]
Schürmann, Mariana [VerfasserIn]
Mikolajewska, Agata [VerfasserIn]
Witzenrath, Martin [VerfasserIn]
Sander, Leif E [VerfasserIn]
Mayer, Beate [VerfasserIn]
Zoller, Thomas [VerfasserIn]

Links:

Volltext

Themen:

Antimalarials
Artemisinin combination therapy
Artemisinins
Hemoglobins
Journal Article
Malaria
Observational Study
Once-infected red blood cells
Post-treatment haemolysis
Research Support, Non-U.S. Gov't
Uncomplicated malaria

Anmerkungen:

Date Completed 22.05.2023

Date Revised 22.05.2023

published: Print

CommentIn: J Travel Med. 2023 May 18;30(3):. - PMID 36799808

Citation Status MEDLINE

doi:

10.1093/jtm/taad001

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM351221026